Comprehensive medication guide to Sumatriptan including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$5–$30 copay for generic sumatriptan on most commercial plans; Tier 1–2 on the majority of formularies. Most plans impose a quantity limit of 9 tablets per 30-day period. Medicare Part D covers sumatriptan on all plans.
Estimated Cash Pricing
$9–$97 retail for generic sumatriptan tablets (9-count); as low as $8.77 for the most common version with a GoodRx coupon. Brand-name Imitrex runs $200–$300 for the same supply.
Medfinder Findability Score
88/100
Summarize with AI
On this page
Sumatriptan is a prescription medication used to treat acute migraine headaches with or without aura in adults. Sold under the brand name Imitrex (and now widely available as a generic), sumatriptan was the first triptan ever approved by the FDA, receiving approval in 1992. It remains the most widely prescribed acute migraine medication in the United States.
Sumatriptan belongs to the class of drugs called selective serotonin (5-HT1B/1D) receptor agonists, commonly known as triptans. It is available in several delivery forms: oral tablets (25 mg, 50 mg, 100 mg), nasal spray (5 mg and 20 mg), subcutaneous injection (4 mg and 6 mg), and nasal powder (Onzetra Xsail, 11 mg per nosepiece). The subcutaneous injection form is also FDA-approved for the acute treatment of cluster headaches.
Sumatriptan is an abortive (acute) treatment — it stops a migraine once it has started but does not prevent future attacks. It is most effective when taken at the very first sign of headache pain, typically within 30–60 minutes of symptom onset for oral tablets, or within 10–15 minutes for subcutaneous injection.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Sumatriptan is structurally similar to serotonin (5-HT) and acts as an agonist at serotonin 5-HT1B and 5-HT1D receptors. These receptors are found on blood vessels around the brain and on trigeminal nerve terminals. During a migraine, the trigeminal nerve releases inflammatory chemicals including calcitonin gene-related peptide (CGRP), which causes dilation of blood vessels in the dura mater and amplifies pain signaling.
Sumatriptan stops migraines through three mechanisms: (1) it constricts dilated dural blood vessels by activating 5-HT1B receptors on vessel walls, (2) it inhibits CGRP and other inflammatory chemical release from trigeminal nerve endings via 5-HT1D receptors, and (3) it blocks pain signal transmission at the trigeminal nucleus caudalis in the brainstem. Together, these effects interrupt the migraine pain cycle.
Oral sumatriptan has a bioavailability of approximately 15% due to extensive first-pass liver metabolism. The subcutaneous injection bypasses this limitation, delivering the drug directly into the subcutaneous tissue for rapid absorption — this is why the injection acts faster (10–15 min) than tablets (30–60 min). Sumatriptan has a half-life of approximately 2.5 hours and is fully cleared from the body within about 10 hours.
25 mg — oral tablet
Lowest oral dose; often sufficient for mild-to-moderate migraine; may be appropriate for those who experience significant side effects at higher doses
50 mg — oral tablet
Most commonly prescribed oral dose; balances efficacy and side effect risk for most patients
100 mg — oral tablet
Highest oral dose; may provide greater effect for some patients but not all; max 200 mg per 24 hours
5 mg — nasal spray
Lower-dose nasal spray; faster onset than tablets; useful when nausea limits ability to swallow
20 mg — nasal spray
Standard nasal spray dose; intermediate onset between tablets and injection
4 mg/0.5 mL — subcutaneous injection
Lower injection dose; fastest onset of all formulations (10-15 min)
6 mg/0.5 mL — subcutaneous injection
Standard injection dose; FDA-approved for both migraine and cluster headaches; 77% cluster headache abort rate within 30 min
11 mg per nosepiece — nasal powder (Onzetra Xsail)
Breath-powered delivery device; 22 mg total dose (both nosepieces); brand-name only
Sumatriptan is generally easy to find in 2026. It is not on the FDA's Drug Shortage Database, and generic sumatriptan is manufactured by multiple companies and widely stocked at pharmacies across the United States. Generic oral tablets (25 mg, 50 mg, 100 mg) are the easiest to find — most chain and independent pharmacies carry them in standard quantities. Nasal spray and injection formulations are less universally stocked and may require calling ahead.
Some patients encounter access barriers that are not related to a true supply shortage. The most common issues are insurance quantity limits (typically 9 tablets per 30-day period), pharmacy-specific stocking variations for less-common strengths, and prior authorization requirements for brand-name formulations. These are navigable with some proactive steps.
If your pharmacy is out of sumatriptan, medfinder can call pharmacies near you to find which ones currently have your medication in stock, so you don't have to call around yourself — especially important when a migraine is already underway.
Because sumatriptan is not a DEA-controlled substance, it can be prescribed by any licensed healthcare provider with prescribing authority. There are no DEA registration requirements, special waiver programs, or mandatory monitoring requirements. This makes sumatriptan one of the most accessible prescription migraine medications for patients to obtain.
Primary care physicians (PCPs) — most common prescribers for episodic migraine management
Neurologists and headache specialists — for complex, chronic, or treatment-resistant migraine
Nurse practitioners (NPs) and physician assistants (PAs) — can prescribe in all 50 states
OB/GYN physicians — commonly prescribe for menstrual migraine management
Emergency medicine physicians and urgent care providers — for immediate migraine treatment
Sumatriptan is widely prescribable via telehealth for patients with an established migraine diagnosis. Services like Teladoc, MDLive, and Amazon Clinic can prescribe sumatriptan after a telehealth consultation, making it accessible for patients without easy access to in-person care.
No. Sumatriptan is not a DEA-scheduled controlled substance. It has no recognized potential for dependence, misuse, or abuse. This means sumatriptan can be prescribed by any licensed healthcare provider in all 50 states without the additional regulatory requirements that apply to controlled substances such as Schedule II–V drugs.
Because sumatriptan is not controlled, it can be prescribed via telehealth without restrictions, transferred between pharmacies, and refilled with standard prescription refill procedures. Patients do not need to obtain a new written prescription at each visit. There are no DEA monitoring requirements, and prescriptions can be called in or sent electronically by any prescriber.
Most sumatriptan side effects are mild and short-lived, typically resolving within 1–2 hours as the drug is metabolized. Common side effects include:
Tingling, pins-and-needles sensations (paresthesias) in the scalp, face, neck, or extremities
Flushing or warm/hot sensation
Dizziness or lightheadedness
Drowsiness or fatigue
Nausea (may overlap with migraine symptoms)
Chest tightness or pressure ("triptan sensation" — usually transient and benign)
Serious side effects (seek emergency care):
Myocardial infarction (heart attack) — severe, prolonged chest pain with shortness of breath
Stroke — sudden weakness, numbness, or difficulty speaking
Serotonin syndrome — agitation, rapid heart rate, high fever, muscle rigidity
Hypertensive crisis — severe elevated blood pressure
Serious allergic reaction (anaphylaxis) — hives, swelling, difficulty breathing
Medication overuse headache (MOH) — using sumatriptan more than 10 days per month can cause rebound headaches
Know what you need? Skip the search.
Rizatriptan (Maxalt)
Fastest-onset oral triptan; available as standard tablet and orally disintegrating tablet (Maxalt-MLT); generic widely available; may provide slightly better pain freedom than sumatriptan for some patients
Eletriptan (Relpax)
Longer half-life (~4-5 hours) than sumatriptan; lower headache recurrence rates; available as generic since 2017; good for patients whose migraines recur after initial triptan relief
Ubrogepant (Ubrelvy)
CGRP receptor antagonist; no vasoconstriction; no cardiovascular contraindications; oral tablet (50 mg, 100 mg); brand-name only; more expensive but appropriate for patients who cannot use triptans
Rimegepant (Nurtec ODT)
CGRP receptor antagonist; dual-use for acute treatment AND prevention of episodic migraine; orally dissolving tablet; brand-name only; appropriate for patients with frequent migraine or cardiovascular contraindications to triptans
Zolmitriptan (Zomig)
Triptan available as tablet, orally disintegrating tablet, and nasal spray; generic available; versatile delivery options
Prefer Sumatriptan? We can find it.
MAOIs (phenelzine, tranylcypromine, linezolid)
majorContraindicated: MAOIs inhibit sumatriptan metabolism, causing dangerous elevation of blood levels. Wait at least 14 days after MAOI discontinuation before using sumatriptan.
Ergotamines (dihydroergotamine, ergotamine tartrate)
majorContraindicated within 24 hours: additive vasospasm risk. Do not use sumatriptan and any ergot-containing medication within 24 hours of each other.
Other triptans (rizatriptan, zolmitriptan, eletriptan, etc.)
majorContraindicated within 24 hours: additive vasoconstrictive effects. Do not combine sumatriptan with any other triptan within a 24-hour window.
SSRIs (fluoxetine, sertraline, escitalopram, paroxetine)
moderateMonitor for serotonin syndrome: increased serotonin activity may cause agitation, confusion, rapid heart rate, high fever, and muscle rigidity. This combination is common and usually manageable with monitoring.
SNRIs (venlafaxine, duloxetine, desvenlafaxine)
moderateMonitor for serotonin syndrome: same mechanism as SSRIs. Disclose all serotonergic antidepressants to prescriber.
Lithium
moderateIncreases serotonin activity; monitor for serotonin syndrome when combined with sumatriptan.
Ozanimod (Zeposia)
majorActive metabolite inhibits MAO-B; coadministration not recommended due to risk of serotonin syndrome and hypertensive crisis.
Sumatriptan is one of the most clinically important and cost-effective migraine medications available. First approved in 1992, it has decades of safety and efficacy data and remains the first-line choice for acute migraine treatment in most clinical guidelines. For the vast majority of migraine patients without cardiovascular contraindications, sumatriptan provides rapid, effective relief at a very low cost.
Generic sumatriptan is widely available in 2026, with no active FDA shortage. With a GoodRx coupon, a 9-tablet supply can cost as little as $8–$15 — making it one of the most affordable prescription migraine options. Patients who face access barriers are most often dealing with insurance quantity limits or pharmacy stocking variability, not a true supply shortage.
If you're struggling to find sumatriptan at your pharmacy, medfinder can help you locate which pharmacies near you currently have it in stock — so you can get your medication quickly when a migraine strikes.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini